Recon: AbbVie’s CEO Gonzalez to depart company after 11 years; FDA halts two of Rapt’s mid-stage immunology trials
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States